Business Context and Reporting Period
Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: January 2025 (Report dated January 30, 2025)
Principal Executive Offices: 5 Ha-Tnufa Street, Yokne-am Illit, Israel 2066736
The filing discloses a private placement offering entered into on January 28, 2025, with a single institutional investor. The transaction involves the issuance of ordinary shares, pre-funded warrants, and warrants, with an expected closing date of January 30, 2025.
Key Financial Metrics and Transaction Details
Offering Structure and Proceeds:
- Aggregate Gross Proceeds: Approximately $2,500,000 (before deducting fees and expenses).
- Ordinary Shares: 345,000 shares issued at $1.00 per share.
- Pre-Funded Warrants: 2,155,000 warrants issued at $0.9999 per warrant (exercise price $0.0001 per share).
- Warrants: 2,500,000 warrants issued with an exercise price of $1.00 per share, exercisable immediately and expiring five years from issuance.
Transaction Costs:
- Placement Agent Fee: 7.0% of aggregate gross proceeds.
- Management Fee: 1.0% of aggregate gross proceeds.
- Expense Reimbursement: Up to $50,000 for legal and other expenses.
Financial Position: The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the capital raise transaction.
Material Changes and Agreements
Warrant Amendment: The Company amended an existing warrant issued on November 26, 2024 (the "November 2024 Warrant"). The exercise price was updated to $1.00 per share, and the termination date was extended to January 30, 2030.
Lock-Up and Issuance Restrictions:
- Insider Lock-Up: Directors and executive officers are restricted from selling securities for 30 days following the closing.
- Company Issuance Moratorium: The Company cannot issue or announce new ordinary shares or equivalents for 45 days post-closing.
- Variable Rate Transaction Ban: The Company is prohibited from conducting variable rate transactions for 180 days post-closing.
Outlook, Risks, and Management Commentary
Use of Proceeds: The filing mentions the use of proceeds in the context of forward-looking statements but does not specify the exact allocation of funds in the text provided.
Risks and Uncertainties: The filing includes standard forward-looking statement disclaimers. Key risks cited include:
- Ability to successfully market products and services.
- Customer acceptance of products.
- Continued ability to pay operating costs and meet demand.
- Competition in security and telecom markets.
- Regulatory compliance.
- Development of a liquid trading market for shares and warrants.
Management Commentary: Management emphasizes that the closing is subject to customary conditions and that actual results may differ materially from expectations due to inherent uncertainties.
Investor Verification Checklist
- Closing Confirmation: Verify if the offering closed on or about January 30, 2025, as expected.
- Net Proceeds: Calculate the net cash received after deducting the 8% total fees (7% placement + 1% management) and up to $50,000 in expenses.
- Dilution Impact: Assess the total dilution from the issuance of 345,000 shares plus the potential conversion of 2,155,000 pre-funded warrants and 2,500,000 standard warrants.
- Beneficial Ownership: Confirm the Purchaser's final beneficial ownership percentage to ensure it adheres to the 4.99% or 9.99% limitation mentioned.
- Registration Status: Verify the effectiveness of the Form F-1 Registration Statement (File No. 333-284023) referenced for the resale of securities.